BioNTech vs ParcelBio
BioNTech vs ParcelBio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioNTech is on 66/100 and ParcelBio on 52/100.
Where each one leads
BioNTech
- our overall score: 66/100 against 52/100
- agent readiness: 40/100 against 33/100
- domain rating: 74/100 against 17/100
- headcount: 5,128 against 6
- funding raised: $975M against $100M
- LinkedIn following: 295,812 against 1,243
ParcelBio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BioNTech | ParcelBio |
|---|---|---|
| What it is | Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. | Advancing next-generation mRNA medicines. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, HealthTech, Artificial Intelligence |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Platform |
| Founded | 2008 | 2023 |
| Headquarters | Mainz, Germany | San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | BioNTech | ParcelBio |
|---|---|---|
| Employees | 5,128 | 6 |
| Total funding | $975M | $100M |
| Latest round | Loan | Series A |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 295,812 | 1,243 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioNTech | ParcelBio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 52/100 |
| Traction | 60/100 | 48/100 |
| Team | 70/100 | Not published |
| Search visibility | 35/100 | 33/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (33/100) |
| Domain ratingLink authority, 0-100 | 74/100 | 17/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioNTech | ParcelBio |
|---|---|---|
| Hosting | Azure | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
| Analytics | Google Tag Manager | Not detected |
BioNTech vs ParcelBio: common questions
Which is better, BioNTech or ParcelBio?
On our 0-100 score BioNTech rates higher (66/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do BioNTech and ParcelBio compare on the numbers?
BioNTech leads on our overall score (66/100 against 52/100), agent readiness (40/100 against 33/100), domain rating (74/100 against 17/100), headcount (5,128 against 6), funding raised ($975M against $100M), LinkedIn following (295,812 against 1,243).
Read the full BioNTech review and pricing or the ParcelBio review and pricing. You can also browse other BioNTech alternatives we track.